Sterivet Laboratories Ltd said it isproceeding with development of a new drug to treat naviculardisease in horses.    The company said it received an unspecified financialcontribution from the National Research Council of Canada tohelp develop the drug for treating navicular disease, whichaffects horses' feet.    Sterivet said the drug has produced promising results inlimited clinical trials conducted over the past 18 months inOntario. Reuter&#3;